+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Therapy Technologies Market Report 2024-2034

  • PDF Icon

    Report

  • 305 Pages
  • April 2024
  • Region: Global
  • Visiongain
  • ID: 5955178
Description Jump to:
Overall world revenue for Cell Therapy Technologies Market, 2024 to 2034 in terms of value the market will surpass US$ 7.04 billion in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Cell Therapy Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Integration of Automation and Robotics into Manufacturing Processes Driving Industry Growth

The integration of automation & robotics within manufacturing sector is propelling the adoption of cell therapy technology. This fusion enhances efficiency, scalability, and reproducibility, while simultaneously mitigating contamination risks. The heightened utilization of closed system bioprocessing technologies further tackles manufacturing challenges by bolstering sterility and safety, all with minimal human intervention.

Nevertheless, obstacles such as steep development costs, intricate manufacturing processes, regulatory complexities, and restricted reimbursement policies pose potential hindrances to industry expansion. To surmount these barriers, there's an escalating demand for cutting-edge analytical tools geared toward quality control and process optimization.

The integration of innovative assays, imaging techniques, and data analytics facilitates real-time monitoring and characterization of cellular products, thereby ensuring heightened efficacy and safety. Additionally, the focus on pioneering biomaterials and scaffolds enhances cell delivery and engraftment, thereby augmenting the allure of cell therapy technologies. Regulatory advancements & collaborations between industry stakeholders & research bodies are fostering innovation and accelerating the transition of cell therapy technologies from laboratory settings to clinical application.

Key Questions Answered

  • How is the cell therapy technologies market evolving?
  • What is driving and restraining the cell therapy technologies market?
  • How will each cell therapy technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each cell therapy technologies submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading cell therapy technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the cell therapy technologies projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of cell therapy technologies projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the cell therapy technologies market?
  • Where is the cell therapy technologies market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell therapy technologies market today, and over the next 10 years:

This 305-page report provides 109 tables and 173 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains an in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the cell therapy technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.- You will find original analyses, with business outlooks and developments.- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments. This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product

  • Sera, Media, Reagent
  • Cell Engineering Product
  • Cell Culture Vessels
  • Equipment
  • Systems and Software
  • Others

Cell Type

  • T-Cells
  • Stem Cells
  • Other Cells

Process

  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control

End-users

  • Biopharmaceutical & Biotechnology Companies
  • CROs, Research Institutes and Cell Banks
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Cell Therapy Technologies Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • Avantor, Inc.
  • Bio-Techne Corporation
  • Bristol-Myers Squibb Company
  • Corning Incorporated
  • Danaher Corporation
  • FUJIFILM Diosynth Biotechnologies
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Lonza
  • Merck KGaA
  • Novartis AG
  • Sartorius AG
  • Terumo BCT
  • Thermo Fisher Scientific Inc.

How will the Cell Therapy Technologies Market, 2024 to 2034 report help you?

In summary, the 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Cell Therapy Technologies Market 2024 to 2034, with forecasts for product, cell type, process, and end-users, each forecast at a global and regional level discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 22 key national markets 
  • See forecasts for the Cell Therapy Technologies Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market including company profiles for 13 of the major companies involved in the Cell Therapy Technologies Market, 2024 to 2034.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Cell Therapy Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Cell Therapy Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Advancements in Cellular Biology
3.2.1.2 Increasing Government Investments in Cell-based Research
3.2.1.3 Technological Advancements
3.2.1.4 Increasing GMP Certifications for Cell Therapy Production Facilities
3.2.2 Market Restraining Factors
3.2.2.1 Challenges Associated with Manufacturing Likely to Restrain Industry Growth
3.2.2.2 Low Success Rate
3.2.2.3 Logistical Challenges Projected to Hamper Industry Growth
3.2.3 Market Opportunities
3.2.3.1 Increased Focus on Personalized Medicine
3.2.3.2 Emergence of iPSCs as Alternatives to ESCs
3.2.3.3 Integration of Digital Health Technologies
3.2.3.4 Expanded Therapeutic Applications
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Cell Therapy Technologies Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Cell Therapy Technologies Market Size Estimation and Forecast by Product
4.4 Sera, Media, Reagent
4.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Cell Engineering Product
4.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Cell Culture Vessels
4.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Equipment
4.7.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Systems and Software
4.8.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Others
4.9.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
4.9.2 Market Share by Region, 2024 & 2034 (%)
5 Cell Therapy Technologies Market Analysis by Cell Type
5.1 Key Findings
5.2 Cell Type Segment: Market Attractiveness Index
5.3 Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
5.4 T-Cells
5.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Stem Cells
5.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Other Cells
5.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2024 & 2034 (%)
6 Cell Therapy Technologies Market Analysis by Process
6.1 Key Findings
6.2 Process Segment: Market Attractiveness Index
6.3 Cell Therapy Technologies Market Size Estimation and Forecast by Process
6.4 Cell Processing
6.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Cell Preservation, Distribution, and Handling
6.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Process Monitoring and Quality Control
6.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
6.6.2 Market Share by Region, 2024 & 2034 (%)
7 Cell Therapy Technologies Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Cell Therapy Technologies Market Size Estimation and Forecast by End-users
7.4 Biopharmaceutical & Biotechnology Companies
7.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 CROs, Research Institutes and Cell Banks
7.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2024 & 2034 (%)
8 Cell Therapy Technologies Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Cell Therapy Technologies Market Analysis
9.1 Key Findings
9.2 North America Cell Therapy Technologies Market Attractiveness Index
9.3 North America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
9.4 North America Cell Therapy Technologies Market Size Estimation and Forecast by Country
9.5 North America Cell Therapy Technologies Market Size Estimation and Forecast by Product
9.6 North America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
9.7 North America Cell Therapy Technologies Market Size Estimation and Forecast by Process
9.8 North America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
9.9 U.S. Cell Therapy Technologies Market Analysis
9.10 Canada Cell Therapy Technologies Market Analysis
10 Europe Cell Therapy Technologies Market Analysis
10.1 Key Findings
10.2 Europe Cell Therapy Technologies Market Attractiveness Index
10.3 Europe Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Country
10.5 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Product
10.6 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
10.7 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Process
10.8 Europe Cell Therapy Technologies Market Size Estimation and Forecast by End-users
10.9 Germany Cell Therapy Technologies Market Analysis
10.10 UK Cell Therapy Technologies Market Analysis
10.11 France Cell Therapy Technologies Market Analysis
10.12 Italy Cell Therapy Technologies Market Analysis
10.13 Spain Cell Therapy Technologies Market Analysis
10.14 Russia Cell Therapy Technologies Market Analysis
10.15 Rest of Europe Cell Therapy Technologies Market Analysis
11 Asia Pacific Cell Therapy Technologies Market Analysis
11.1 Key Findings
11.2 Asia Pacific Cell Therapy Technologies Market Attractiveness Index
11.3 Asia Pacific Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Country
11.5 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Product
11.6 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
11.7 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Process
11.8 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by End-users
11.9 Japan Cell Therapy Technologies Market Analysis
11.10 China Cell Therapy Technologies Market Analysis
11.11 India Cell Therapy Technologies Market Analysis
11.12 Australia Cell Therapy Technologies Market Analysis
11.13 South Korea Cell Therapy Technologies Market Analysis
11.14 South-East Asia Cell Therapy Technologies Market Analysis
11.15 Rest of Asia Pacific Cell Therapy Technologies Market Analysis
12 Latin America Cell Therapy Technologies Market Analysis
12.1 Key Findings
12.2 Latin America Cell Therapy Technologies Market Attractiveness Index
12.3 Latin America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
12.4 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Country
12.5 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Product
12.6 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
12.7 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Process
12.8 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
12.9 Brazil Cell Therapy Technologies Market Analysis
12.10 Mexico Cell Therapy Technologies Market Analysis
12.11 Rest of Latin America Cell Therapy Technologies Market Analysis
13 MEA Cell Therapy Technologies Market Analysis
13.1 Key Findings
13.2 MEA Cell Therapy Technologies Market Attractiveness Index
13.3 MEA Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
13.4 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Country
13.5 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Product
13.6 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
13.7 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Process
13.8 MEA Cell Therapy Technologies Market Size Estimation and Forecast by End-users
13.9 GCC Cell Therapy Technologies Market Analysis
13.10 South Africa Cell Therapy Technologies Market Analysis
13.11 Rest of MEA Cell Therapy Technologies Market Analysis
14 Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2018-2023
14.1.3.2 Regional Market Shares, 2022
14.1.3.3 R&D, 2018-2023
14.1.4 Product Benchmarking
14.1.5 Strategic Outlook
14.2 Novartis AG
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2018-2023
14.2.3.2 Regional Market Shares, 2022
14.2.3.3 R&D, 2018-2023
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Gilead Sciences, Inc.
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2018-2023
14.3.3.2 R&D, 2018-2023
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 Merck KGaA
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2018-2023
14.4.3.2 Regional Market Shares, 2023
14.4.3.3 R&D, 2018-2023
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Danaher Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2018-2023
14.5.3.2 Regional Market Shares, 2023
14.5.3.3 R&D, 2018-2023
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Bristol-Myers Squibb Company
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2018-2023
14.6.3.2 Regional Market Shares, 2023
14.6.3.3 R&D, 2018-2023
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Sartorius AG
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2018-2023
14.7.3.2 Regional Market Shares, 2023
14.7.3.3 R&D, 2018-2023
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 FUJIFILM Diosynth Biotechnologies
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Lonza
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2018-2023
14.9.3.2 Regional Market Shares, 2023
14.9.3.3 R&D, 2018-2022
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 GE Healthcare
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2018-2023
14.10.3.2 Regional Market Shares, 2022
14.10.3.3 R&D, 2018-2023
14.10.4 Product Benchmarking
14.11 Terumo BCT
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2018-2023
14.11.3.2 Regional Market Shares, 2022
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Avantor, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2018-2023
14.12.3.2 Regional Market Shares, 2023
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Bio-Techne Corporation
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2018-2023
14.13.3.2 R&D, 2018-2023
14.13.4 Product Benchmarking
14.13.5 Strategic Outlook
14.14 Corning Incorporated
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2018-2023
14.14.3.2 Regional Market Shares, 2023
14.14.3.3 R&D, 2018-2023
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 Cell Therapy Technologies Market Snapshot, 2024 & 2034 (US$ million, CAGR %)
Table 2 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 7 Sera, Media, Reagents Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 8 Cell Engineering Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 9 Cell Culture Vessels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 10 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Systems and Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 14 T-Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 15 Stem Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 16 Other Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Cell Preservation, Distribution, and Handling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Process Monitoring and Quality Control Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Biopharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 CROs, Research Institutes and Cell Banks Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 North America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 26 North America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 27 North America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 North America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 North America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 30 U.S. Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 Canada Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 32 Europe Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 33 Europe Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Europe Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 35 Europe Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 Europe Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 37 Germany Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 UK Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 France Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Italy Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 Spain Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 42 Russia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 43 Rest of Europe Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 Asia Pacific Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 Asia Pacific Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 47 Asia Pacific Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 49 Japan Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 50 China Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 51 India Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 Australia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 53 South Korea Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 54 South-East Asia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 56 Latin America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Latin America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 Latin America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 Latin America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 61 Brazil Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 62 Mexico Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 63 Rest of Latin America Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 64 MEA Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 MEA Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 66 MEA Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 67 MEA Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 68 MEA Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 69 GCC Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 70 South Africa Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 71 Rest of MEA Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 72 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 74 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 75 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Novartis AG: Product Benchmarking
Table 77 Novartis AG: Strategic Outlook
Table 78 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Gilead Sciences, Inc.: Product Benchmarking
Table 80 Gilead Sciences, Inc.: Strategic Outlook
Table 81 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Merck KGaA: Product Benchmarking
Table 83 Merck KGaA: Strategic Outlook
Table 84 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Danaher Corporation: Product Benchmarking
Table 86 Danaher Corporation: Strategic Outlook
Table 87 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Bristol-Myers Squibb Company: Product Benchmarking
Table 89 Bristol-Myers Squibb Company: Strategic Outlook
Table 90 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Sartorius AG: Product Benchmarking
Table 92 Sartorius AG: Strategic Outlook
Table 93 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 FUJIFILM Diosynth Biotechnologies: Product Benchmarking
Table 95 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 96 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Lonza: Product Benchmarking
Table 98 Lonza: Strategic Outlook
Table 99 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 GE Healthcare: Product Benchmarking
Table 101 Terumo BCT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Terumo BCT: Product Benchmarking
Table 103 Terumo BCT: Strategic Outlook
Table 104 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Avantor, Inc.: Product Benchmarking
Table 106 Avantor, Inc.: Strategic Outlook
Table 107 Bio-Techne Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Bio-Techne Corporation: Product Benchmarking
Table 109 Bio-Techne Corporation: Strategic Outlook
Table 110 Corning Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Corning Incorporated: Product Benchmarking
Table 112 Corning Incorporated: Strategic Outlook
List of Figures
Figure 1 Cell Therapy Technologies Market Segmentation
Figure 2 Cell Therapy Technologies Market by Product: Market Attractiveness Index
Figure 3 Cell Therapy Technologies Market by Cell Type: Market Attractiveness Index
Figure 4 Cell Therapy Technologies Market by Process: Market Attractiveness Index
Figure 5 Cell Therapy Technologies Market by End-users: Market Attractiveness Index
Figure 6 Cell Therapy Technologies Market Attractiveness Index by Region
Figure 7 Cell Therapy Technologies Market: Market Dynamics
Figure 8 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “V” Shaped Recovery
Figure 9 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “U” Shaped Recovery
Figure 10 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “W” Shaped Recovery
Figure 11 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): “L” Shaped Recovery
Figure 12 Cell Therapy Technologies Market: Porter’s Five Forces Analysis
Figure 13 Cell Therapy Technologies Market: PEST Analysis
Figure 14 Cell Therapy Technologies Market Attractiveness Index by Product
Figure 15 Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 16 Cell Therapy Technologies Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 17 Sera, Media, Reagent Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 18 Sera, Media, Reagent Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Cell Engineering Product Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 20 Cell Engineering Product Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Cell Culture Vessels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 22 Cell Culture Vessels Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 24 Equipment Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Systems and Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 26 Systems and Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 28 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Cell Therapy Technologies Market Attractiveness Index by Product
Figure 30 Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 31 Cell Therapy Technologies Market Share Forecast by Cell Type, 2024, 2029, 2034 (%)
Figure 32 T-Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 33 T-Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Stem Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 35 Stem Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Other Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 37 Other Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Cell Therapy Technologies Market Attractiveness Index by Process
Figure 39 Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 40 Cell Therapy Technologies Market Share Forecast by Process, 2024, 2029, 2034 (%)
Figure 41 Cell Processing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 42 Cell Processing Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Cell Preservation, Distribution, and Handling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 44 Cell Preservation, Distribution, and Handling Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Process Monitoring and Quality Control Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 46 Process Monitoring and Quality Control Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Cell Therapy Technologies Market Attractiveness Index by End-users
Figure 48 Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 49 Cell Therapy Technologies Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 50 Biopharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 51 Biopharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 CROs, Research Institutes and Cell Banks Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 53 CROs, Research Institutes and Cell Banks Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Cell Therapy Technologies Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
Figure 55 Cell Therapy Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 56 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Mn)
Figure 57 North America Cell Therapy Technologies Market Attractiveness Index
Figure 58 North America Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 59 North America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
Figure 60 North America Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 61 North America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 62 North America Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
Figure 63 North America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 64 North America Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
Figure 65 North America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 66 North America Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
Figure 67 North America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 68 North America Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 69 U.S. Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 70 Canada Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 71 Europe Cell Therapy Technologies Market Attractiveness Index
Figure 72 Europe Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 73 Europe Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
Figure 74 Europe Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 75 Europe Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 76 Europe Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
Figure 77 Europe Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 78 Europe Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
Figure 79 Europe Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 80 Europe Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
Figure 81 Europe Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 82 Europe Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 83 Germany Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 84 UK Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 85 France Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 86 Italy Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 87 Spain Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 88 Russia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 89 Rest of Europe Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 90 Asia Pacific Cell Therapy Technologies Market Attractiveness Index
Figure 91 Asia Pacific Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 92 Asia Pacific Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
Figure 93 Asia Pacific Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 94 Asia Pacific Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 95 Asia Pacific Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
Figure 96 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 97 Asia Pacific Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
Figure 98 Asia Pacific Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 99 Asia Pacific Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
Figure 100 Asia Pacific Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 101 Asia Pacific Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 102 Japan Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 103 China Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 104 India Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 105 Australia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 106 South Korea Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 107 South-East Asia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 109 Latin America Cell Therapy Technologies Market Attractiveness Index
Figure 110 Latin America Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 111 Latin America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
Figure 112 Latin America Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 113 Latin America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 114 Latin America Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
Figure 115 Latin America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 116 Latin America Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
Figure 117 Latin America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 118 Latin America Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
Figure 119 Latin America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 120 Latin America Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 121 Brazil Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 122 Mexico Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 123 Rest of Latin America Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 124 MEA Cell Therapy Technologies Market Attractiveness Index
Figure 125 MEA Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 126 MEA Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
Figure 127 MEA Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 128 MEA Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 129 MEA Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
Figure 130 MEA Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
Figure 131 MEA Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
Figure 132 MEA Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
Figure 133 MEA Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
Figure 134 MEA Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
Figure 135 MEA Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 136 GCC Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 137 South Africa Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 138 Rest of MEA Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 139 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 140 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2022
Figure 141 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 142 Novartis AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 143 Novartis AG: Regional Market Shares (%), 2022
Figure 144 Novartis AG: R&D, 2018-2023 (US$ Million, AGR%)
Figure 145 Gilead Sciences, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 146 Gilead Sciences, Inc.: R&D, 2018-2023 (US$ Million, AGR%)
Figure 147 Merck KGaA: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 148 Merck KGaA: Regional Market Shares (%), 2023
Figure 149 Merck KGaA: R&D, 2018-2023 (US$ Million, AGR%)
Figure 150 Danaher Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 151 Danaher Corporation: Regional Market Shares (%), 2023
Figure 152 Danaher Corporation: R&D, 2018-2023 (US$ Million, AGR%)
Figure 153 Bristol-Myers Squibb Company: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 154 Bristol-Myers Squibb Company: Regional Market Shares (%), 2023
Figure 155 Bristol-Myers Squibb Company: R&D, 2018-2023 (US$ Million, AGR%)
Figure 156 Sartorius AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 157 Sartorius AG: Regional Market Shares (%), 2023
Figure 158 Sartorius AG: R&D, 2018-2023 (US$ Million, AGR%)
Figure 159 Lonza: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 160 Lonza: Regional Market Shares (%), 2023
Figure 161 Lonza: R&D, 2018-2022 (US$ Million, AGR%)
Figure 162 GE Healthcare: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 163 GE Healthcare: Regional Market Shares (%), 2022
Figure 164 GE Healthcare: R&D, 2018-2023 (US$ Million, AGR%)
Figure 165 Terumo BCT: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 166 Terumo BCT: Regional Market Shares (%), 2022
Figure 167 Avantor, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 168 Avantor, Inc.: Regional Market Shares (%), 2023
Figure 169 Bio-Techne Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 170 Bio-Techne Corporation: R&D, 2018-2023 (US$ Million, AGR%)
Figure 171 Corning Incorporated: Net Revenue, 2018-2023 (US$ Million, AGR%)
Figure 172 Corning Incorporated: Regional Market Shares (%), 2023
Figure 173 Corning Incorporated: R&D, 2018-2023 (US$ Million, AGR%)

Companies Mentioned

  • Avantor, Inc.
  • Bio-Techne Corporation
  • Bristol-Myers Squibb Company
  • Corning Incorporated
  • Danaher Corporation
  • FUJIFILM Diosynth Biotechnologies
  • GE Healthcare
  • Gilead Sciences, Inc.
  • Lonza
  • Merck KGaA
  • Novartis AG
  • Sartorius AG
  • Terumo BCT
  • Thermo Fisher Scientific Inc.
  • Arsenal Biosciences, Inc.
  • Autolus Therapeutics plc
  • Bayer AG
  • BioNTech SE
  • BlueRock Therapeutics
  • Byers Capital
  • Bellicum Pharmaceuticals, Inc.
  • BioCentriq
  • Cellares
  • Century Therapeutics
  • Charles River Laboratories International, Inc.
  • Chimin Health
  • Coeptis Therapeutics Holdings, Inc.
  • CTRL Therapeutics
  • Eli Lilly and Company
  • Emerson Collective Investments
  • Euclidean Capital
  • FibroBiologics
  • FACIT
  • General Catalyst
  • Gracell Biotechnologies Inc.
  • Green Sands
  • Hitachi Ventures
  • Intermountain Health
  • Kleiner Perkins
  • NK:IO Limited
  • Opsis Therapeutics, LLC
  • S.Biomedics
  • Sigilon Therapeutics, Inc.
  • Sixth Street
  • Softbank
  • Tata Memorial Hospital
  • VyGen-Bio, Inc.
  • Waycross Ventures
  • Central Drugs Standard Control Organisation (CDSCO)
  • Japan Patent Office
  • MD Anderson
  • Parker Institute for Cancer Immunotherapy (PICI)
  • The University of Texas

Related Topics

Related Reports

NK Cell Therapy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

NK Cell Therapy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Allogeneic T-cell therapy for autoimmune diseases - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Allogeneic T-cell therapy for autoimmune diseases - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 130 Pages
  • Global
From
CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034 - Product Image

CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region - Product Image

Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region

  • Report
  • 200 Pages
  • Global
From

About the Cell Therapy Market

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders. Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.